[1] Feng M,Ben-Josef E. Radiation therapy for hepatocellular carcinoma. Semin Radiat Oncol,2011,21:271-277. [2] Benson R,Madan R,Kilambi R,et al. Radiation induced liver disease:A clinical update. J Egyp N Ca Inst,2016,28: 7-11. [3] 申文江,王绿叶.放射治疗损伤. 北京:中国医药科技出版社,2001:131. [4] 高东伟,于甬华. 细胞因子与放射性肝损. 实用肝脏病杂志,2006,9:249-251. [5] 原发性肝癌规范化诊治的专家共识. 实用肝脏病杂志,2009,12:321-327. [6] Marks LB,Yorke ED,Jackson A,et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys,2010,76:10-19. [7] Guha C,Kavanagh BD. Hepatic radiation toxicity: avoidance and amelioration. Semin Radiat Oncol,2011,21:256-263. [8] Cheng JC,Wu JK,Huang CM,et al. Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description. Int J Radiat Oncol Biol Phys,2002,53:156-162. [9] Liang SX,Zhu XD,Lu HJ,et al. Hypofractionated three dimensional conformal radiation therapy for primary liver carcinoma. Cancer,2005,103:2181-2188. [10] Stenmark MH,Cao Y,Wang H,et al. Estimating functional liver reserve following hepatic irradiation:adaptive normal tissue response models. Radiother Oncol,2014,111:418-423. [11] Ingold JA,Reed GB,Kaplan HS,et al.Radiation hepatitis. Am J Roentgenol,1965,93:200-208. [12] Wickremesekera J K,Chen W,Cannan R J,et al. Serum proinflammatory cytokine response in patients with advanced liver tumors following selective internal radiation therapy with 90 Yttrium microspheres. Int J Radiat Oncol Biol Phys,2001,49:1015-1021. [13] Gencel O,Naziroglu M,Celik O,et al. Selenium and vitamin E modulates radiation induced liver toxicity in pregnant and nonpregnant rat:effects of colemanite and hematite shielding. Biol Trace Elem Res,2010,135:253-263. [14] Feng M,Smith DE,Normolle DP,et al. A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy. Int J Radiat Oncol Biol Phys,2012,83:1441-1447. [15] Kim TH,Kim DY,Park JW,et al. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys,2007,67(1):225-231. [16] Liang SX,Huang XB,Zhu XD,et al. Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child-Pugh grade A cirrhosis. Radiat Oncol,2011,98:265-269. [17] Jung J,Yoon SM,Kim SY,et al. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma:clinical and dose-volumetric parameters. Radiat Oncol,2013,8:249. [18] Huang Y,Chen SW,Fan CC,et al. Clinical parameters for predicting radiation-induced liver disease after intrahepatic reirradiation for hepatocellular carcinoma. Radiat Oncol,2016,11:89. [19] 张宁宁,程晓静,刘建勇,等. 非手术治疗原发性肝癌研究进展. 实用肝脏病杂志,2016,19:249-252. |